References
- Aloisio, E., et al. (2020). “A Comprehensive Appraisal of Laboratory Biochemistry Tests as Major Predictors of COVID-19 Severity.” Arch Pathol Lab Med 144(12): 1457-1464.
2. Antunez Muiños, P. J., et al. (2021). “The COVID-19 lab score: an accurate dynamic tool to predict in-hospital outcomes in COVID-19 patients.” Sci Rep 11(1): 9361.
3. Asghar, M. S., et al. (2020). “Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country.” Cureus 12(8): e9575.
4. Bastug, A., et al. (2020). “Clinical and laboratory features of COVID-19: Predictors of severe prognosis.” Int Immunopharmacol 88: 106950.
5. Cao, J., et al. (2020). “Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease.” Theranostics 10(21): 9663-9673.
6. Carlino, M. V., et al. (2020). “Predictors of Intensive Care Unit admission in patients with coronavirus disease 2019 (COVID-19).” Monaldi Arch Chest Dis 90(3).
7. Chen, F. F., et al. (2020). “The characteristics and outcomes of 681 severe cases with COVID-19 in China.” J Crit Care 60: 32-37.
8. Chen, H., et al. (2021). “Cardiac Troponin I association with critical illness and death risk in 726 seriously ill COVID-19 patients: A retrospective cohort study.” Int J Med Sci 18(6): 1474-1483.
9. Chen, L., et al. (2021). “Association of coagulation dysfunction with cardiac injury among hospitalized patients with COVID-19.” Sci Rep 11(1): 4432.
10. Chen, L., et al. (2020). “Risk factors for death in 1859 subjects with COVID-19.” Leukemia 34(8): 2173-2183.
11. Chen, X., et al. (2020). “A Retrospective Analysis of the Coagulation Dysfunction in COVID-19 Patients.” Clin Appl Thromb Hemost 26: 1076029620964868.
12. Cheng, A., et al. (2020). “Diagnostic performance of initial blood urea nitrogen combined with D-dimer levels for predicting in-hospital mortality in COVID-19 patients.” Int J Antimicrob Agents 56(3): 106110.
13. Cheng, B., et al. (2020). “Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.” Clin Microbiol Infect 26(10): 1400-1405.
14. Cheng, S., et al. (2020). “Risk factors for the critical illness in SARS-CoV-2 infection: a multicenter retrospective cohort study.” Respir Res 21(1): 277.
15. Chocron, R., et al. (2021). “D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study.” Arch Cardiovasc Dis.
16. Cipriani, A., et al. (2021). “Cardiac injury and mortality in patients with Coronavirus disease 2019 (COVID-19): insights from a mediation analysis.” Intern Emerg Med 16(2): 419-427.
17. Creel-Bulos, C., et al. (2020). “Trends and diagnostic value of D-dimer levels in patients hospitalized with coronavirus disease 2019.” Medicine (Baltimore) 99(46): e23186.
18. De Michieli, L., et al. (2021). “Using high sensitivity cardiac troponin values in patients with SARS-CoV-2 infection (COVID-19): The Padova experience.” Clin Biochem 90: 8-14.
19. Deng, P., et al. (2020). “The diagnostic and prognostic role of myocardial injury biomarkers in hospitalized patients with COVID-19.” Clin Chim Acta 510: 186-190.
20. Donoso-Navarro, E., et al. (2021). “IL-6 and Other Biomarkers associated with Poor Prognosis in a Cohort of Hospitalized Patients with COVID-19 in Madrid.” Biomark Insights 16: 11772719211013363.
21. Duan, J., et al. (2020). “Correlation between the variables collected at admission and progression to severe cases during hospitalization among patients with COVID-19 in Chongqing.” J Med Virol 92(11): 2616-2622.
22. El-Solh, A. A., et al. (2020). “Comparison of in-hospital mortality risk prediction models from COVID-19.” PLoS One 15(12): e0244629.
23. El-Solh, A. A., et al. (2021). “Clinical Course and Outcome of COVID-19 Acute Respiratory Distress Syndrome: Data From a National Repository.” J Intensive Care Med 36(6): 664-672.
24. Fu, J., et al. (2020). “The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.” Thromb Res 192: 3-8.
25. Gao, Y., et al. (2020). “Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.” J Med Virol 92(7): 791-796.
26. Goudot, G., et al. (2020). “Predictive Factor for COVID-19 Worsening: Insights for High-Sensitivity Troponin and D-Dimer and Correlation With Right Ventricular Afterload.” Front Med (Lausanne) 7: 586307.
27. Gu, Y., et al. (2021). “PaO(2)/FiO(2) and IL-6 are risk factors of mortality for intensive care COVID-19 patients.” Sci Rep 11(1): 7334.
28. Gupta, R. K., et al. (2021). “Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study.” Lancet Respir Med 9(4): 349-359.
29. Han, H., et al. (2020). “Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.” Emerg Microbes Infect 9(1): 1123-1130.
30. Harmouch, F., et al. (2021). “Is it all in the heart? Myocardial injury as major predictor of mortality among hospitalized COVID-19 patients.” J Med Virol 93(2): 973-982.
31. He, X., et al. (2021). “The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients.” Sci Rep 11(1): 1830.
32. Herold, T., et al. (2020). “Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19.” J Allergy Clin Immunol 146(1): 128-136.e124.
33. Huang, Y., et al. (2020). “A cohort study of 676 patients indicates D-dimer is a critical risk factor for the mortality of COVID-19.” PLoS One 15(11): e0242045.
34. Huff, H. V. and A. Singh (2020). “Asymptomatic Transmission During the Coronavirus Disease 2019 Pandemic and Implications for Public Health Strategies.” Clin Infect Dis 71(10): 2752-2756.
35. Infante, M., et al. (2021). “Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study.” J Am Coll Nutr: 1-16.
36. Jin, X., et al. (2020). “The values of coagulation function in COVID-19 patients.” PLoS One 15(10): e0241329.
37. Jøntvedt Jørgensen, M., et al. (2020). “Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19.” Sci Rep 10(1): 21697.
38. Kaufmann, C. C., et al. (2021). “Mid-regional pro-atrial natriuretic peptide independently predicts short-term mortality in COVID-19.” Eur J Clin Invest 51(5): e13531.
39. Ke, C., et al. (2020). “Clinical characteristics of confirmed and clinically diagnosed patients with 2019 novel coronavirus pneumonia: a single-center, retrospective, case-control study.” Med Clin (Engl Ed) 155(8): 327-334.
40. Keski, H. (2021). “Hematological and Inflammatory Parameters to Predict the Prognosis in COVID-19.” Indian J Hematol Blood Transfus: 1-9.
41. Küçükceran, K., et al. (2021). “Predictive value of D-dimer/albumin ratio and fibrinogen/albumin ratio for in-hospital mortality in patients with COVID-19.” Int J Clin Pract: e14263.
42. Laguna-Goya, R., et al. (2020). “IL-6-based mortality risk model for hospitalized patients with COVID-19.” J Allergy Clin Immunol 146(4): 799-807.e799.
43. Liang, M., et al. (2020). “Novel risk scoring system for predicting acute respiratory distress syndrome among hospitalized patients with coronavirus disease 2019 in Wuhan, China.” BMC Infect Dis 20(1): 960.
44. Liu, F., et al. (2020). “Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.” J Clin Virol 127: 104370.
45. Liu, Q., et al. (2020). “Laboratory findings and a combined multifactorial approach to predict death in critically ill patients with COVID-19: a retrospective study.” Epidemiol Infect 148: e129.
46. Liu, S. L., et al. (2020). “Expressions of SAA, CRP, and FERR in different severities of COVID-19.” Eur Rev Med Pharmacol Sci 24(21): 11386-11394.
47. Long, H., et al. (2020). “D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis.” Biomed Res Int 2020: 6159720.
48. Luo, H. C., et al. (2021). “Characteristics of coagulation alteration in patients with COVID-19.” Ann Hematol 100(1): 45-52.
49. Luo, X., et al. (2020). “Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019.” Clin Infect Dis 71(16): 2174-2179.
50. Luo, Y., et al. (2020). “Prealbumin as a Predictor of Prognosis in Patients With Coronavirus Disease 2019.” Front Med (Lausanne) 7: 374.
51. Macias-Muñoz, L., et al. (2021). “Value of clinical laboratory test for early prediction of mortality in patients with COVID-19: the BGM score.” J Circ Biomark 10: 1-8.
52. Maeda, T., et al. (2021). “The association of interleukin-6 value, interleukin inhibitors, and outcomes of patients with COVID-19 in New York City.” J Med Virol 93(1): 463-471.
53. Manocha, K. K., et al. (2021). “Troponin and Other Biomarker Levels and Outcomes Among Patients Hospitalized With COVID-19: Derivation and Validation of the HA(2)T(2) COVID-19 Mortality Risk Score.”
54. Montrucchio, G., et al. (2021). “Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study.” PLoS One 16(2): e0246771.
55. Mueller, A. A., et al. (2020). “Inflammatory Biomarker Trends Predict Respiratory Decline in COVID-19 Patients.” Cell Rep Med 1(8): 100144.
56. Muhammad, R., et al. (2021). “Clinical Characteristics and Predictors of Mortality in Minority Patients Hospitalized with COVID-19 Infection.” J Racial Ethn Health Disparities: 1-11.
57. Myhre, P. L., et al. (2020). “Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19.” Circulation 142(22): 2128-2137.
58. Nagant, C., et al. (2020). “A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer.” Int J Infect Dis 101: 342-345.
59. Nascimento, J. H. P., et al. (2021). “COVID-19 and Myocardial Injury in a Brazilian ICU: High Incidence and Higher Risk of In-Hospital Mortality.” Arq Bras Cardiol 116(2): 275-282.
60. Naymagon, L., et al. (2020). “Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19.” Thromb Res 196: 99-105.
61. Otoshi, R., et al. (2021). “Clinical characteristics of Japanese patients with moderate to severe COVID-19.” J Infect Chemother 27(6): 895-901.
62. Özyılmaz, S., et al. (2020). “Assessment of the Relationship between Mortality and Troponin I Levels in Hospitalized Patients with the Novel Coronavirus (COVID-19).” Medicina (Kaunas) 56(12).
63. Pan, M., et al. (2021). “Laboratory predictors of severe Coronavirus Disease 2019 and lung function in followed-up.” Clin Respir J.
64. Pascual Gómez, N. F., et al. (2020). “[Potential biomarkers predictors of mortality in COVID-19 patients in the Emergency Department].” Rev Esp Quimioter 33(4): 267-273.
65. Patel, K. P., et al. (2020). “Transmission of SARS-CoV-2: an update of current literature.” Eur J Clin Microbiol Infect Dis 39(11): 2005-2011.
66. Peiró Ó, M., et al. (2021). “Biomarkers and short-term prognosis in COVID-19.” Biomarkers 26(2): 119-126.
67. Pieri, M., et al. (2021). “Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis.” Int Immunopharmacol 95: 107512.
68. Pouw, N., et al. (2021). “Clinical characteristics and outcomes of 952 hospitalized COVID-19 patients in The Netherlands: A retrospective cohort study.” PLoS One 16(3): e0248713.
69. Qin, Z. J., et al. (2020). “Impaired immune and coagulation systems may be early risk factors for COVID-19 patients: A retrospective study of 118 inpatients from Wuhan, China.” Medicine (Baltimore) 99(35): e21700.
70. Quartuccio, L., et al. (2021). “Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia.” Cytokine 140: 155438.
71. Rubio-Rivas, M., et al. (2021). “Risk Categories in COVID-19 Based on Degrees of Inflammation: Data on More Than 17,000 Patients from the Spanish SEMI-COVID-19 Registry.” J Clin Med 10(10).
72. Salinas, M., et al. (2020). “Laboratory parameters in patients with COVID-19 on first emergency admission is different in non-survivors: albumin and lactate dehydrogenase as risk factors.” J Clin Pathol.
73. Santa Cruz, A., et al. (2021). “Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia.” Front Immunol 12: 613422.
74. Satış, H., et al. (2021). “Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19.” Cytokine 137: 155302.
75. Selcuk, M., et al. (2021). “Comparison of D-dimer Level Measured on the Third Day of Hospitalization with Admission D-dimer Level in Predicting In-hospital Mortality in COVID-19 Patients.” Medeni Med J 36(1): 1-6.
76. Shang, M., et al. (2021). “Early Warning Factors of Death in COVID-19 Patients.” Curr Med Sci 41(1): 69-76.
77. Shang, W., et al. (2020). “The value of clinical parameters in predicting the severity of COVID-19.” J Med Virol 92(10): 2188-2192.
78. Sharif, F., et al. (2021). “Early hematological indicators of severe COVID-19 disease in hospitalized patients: Data from a South Asian population.” Int J Lab Hematol.
79. Shi, S., et al. (2021). “Clinical and laboratory characteristics of severe and non-severe patients with COVID-19: A retrospective cohort study in China.” J Clin Lab Anal 35(1): e23692.
80. Shi, X., et al. (2020). “[Value of interleukin-6 and CD4(+) T-lymphocytopenia in assessing the severity and prognosis of coronavirus disease 2019].” Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 32(10): 1165-1170.
81. Smilowitz, N. R., et al. (2021). “C-reactive protein and clinical outcomes in patients with COVID-19.” Eur Heart J 42(23): 2270-2279.
82. Soni, M., et al. (2020). “D-dimer level is a useful predictor for mortality in patients with COVID-19: Analysis of 483 cases.” Diabetes Metab Syndr 14(6): 2245-2249.
83. Tahtasakal, C. A., et al. (2021). “Could we predict the prognosis of the COVID-19 disease?” J Med Virol 93(4): 2420-2430.
84. Tian, W., et al. (2020). “Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.” J Med Virol 92(10): 1875-1883.
85. van Dam, P., et al. (2021). “Performance of prediction models for short-term outcome in COVID-19 patients in the emergency department: a retrospective study.” Ann Med 53(1): 402-409.
86. Wang, D., et al. (2020). “Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study.” BMC Infect Dis 20(1): 519.
87. Wang, M., et al. (2020). “Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.” Infect Genet Evol 85: 104511.
88. Wang, Y., et al. (2021). “The peak levels of highly sensitive troponin I predicts in-hospital mortality in COVID-19 patients with cardiac injury: a retrospective study.” Eur Heart J Acute Cardiovasc Care 10(1): 6-15.
89. Wang, Y., et al. (2020). “Cardiac Injury and Clinical Course of Patients With Coronavirus Disease 2019.” Front Cardiovasc Med 7: 147.
90. Wang, Z. and Z. Wang (2021). “Identification of risk factors for in-hospital death of COVID – 19 pneumonia — lessions from the early outbreak.” BMC Infect Dis 21(1): 113.
91. Xu, F., et al. (2021). “Prediction of Disease Progression of COVID-19 Based upon Machine Learning.” Int J Gen Med 14: 1589-1598.
92. Yang, A. P., et al. (2020). “Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients.” Aging (Albany NY) 12(11): 10059-10069.
93. Yao, Y., et al. (2020). “D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study.” J Intensive Care 8: 49.
94. Ye, W., et al. (2020). “Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.” Respir Res 21(1): 169.
95. Ye, Y., et al. (2021). “Prediction and follow-up of risk factors for severe SARS-CoV-2 pneumonia and application of CT visual scoring.” Technol Health Care 29(S1): 153-164.
96. Yu, J., et al. (2020). “Prognostic Value of a Clinical Biochemistry-Based Nomogram for Coronavirus Disease 2019.” Front Med (Lausanne) 7: 597791.
97. Yue, T., et al. (2021). “Combined clinical and imaging features better predict the critical outcomes of patients with SARS-COV-2.” Medicine (Baltimore) 100(12): e25083.
98. Zayat, R., et al. (2020). “Role of extracorporeal membrane oxygenation in critically Ill COVID-19 patients and predictors of mortality.” Artif Organs.
99. Zhang, J., et al. (2020). “Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study.” J Transl Med 18(1): 406.
100. Zhang, J., et al. (2021). “Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.” Front Immunol 12: 581469.
101. Zhang, L., et al. (2020). “D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.” J Thromb Haemost 18(6): 1324-1329.
102. Zhao, Y., et al. (2021). “Peripheral blood inflammatory markers in predicting prognosis in patients with COVID-19. Some differences with influenza A.” J Clin Lab Anal 35(1): e23657.
103. Zhu, Y., et al. (2020). “Evaluation of organ function in patients with severe COVID-19 infections.” Med Clin (Engl Ed) 155(5): 191-196.
COVID-19
The Keith Peters Building,
Hills Road, Cambridge, CB2 0XY
Site content © CIMR 2022